Venture
Affiliations
Columbia University
Technologies
Therapeutic
Indication
Basic Research
Central Nervous System Disorders
Pain Management
Website
www.kuresinc.comI am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression.
Kures, Inc. Team: